Showing 131-140 of 878 results for "".
ILUMYA SUPPORT™ patient access for commercial and Medicare Part B patients
https://practicaldermatology.com/topics/psoriasis/ilumya-support-patient-access-for-commercial-and-medicare-part-b-patients/19860/ILUMYA SUPPORT™ offers comprehensive programs and services to help patients start and stay on therapy with ILUMYA™. Learn about the three main patient access programs offered by ILUMYA SUPPORT™: the Early Access Program, the Co-pay Program, and the Patient Assistance Program. ILUMYA™ is reimbursed uSocial Media as a Force for Good: How to Think Like a B Corp
https://practicaldermatology.com/topics/practice-management/social-media-as-a-force-for-good-how-to-think-like-a-b-corp/24009/For dermatologists, social media networks are underutilized when marketing their practices—create quality and trusted material, deliver practice-specific messaging strategies, and convey and sustain reliable information.MIPS: The Secret to His Success
https://practicaldermatology.com/topics/practice-management/mips-the-secret-to-his-success/23117/Windsor Dermatology’s Dr. David Nieves shares his successful MIPS action plan.How to Deal with Hagglers and Other Tough Patients
https://practicaldermatology.com/topics/practice-management/how-to-deal-with-hagglers-and-other-tough-patients/19211/Michael J. Sacopulos, JD offers strategies for handling difficult patients and how to negotiate with hagglers.TELEMEDICINE AND ONLINE PRESENCE
https://practicaldermatology.com/topics/practice-management/matv-sacopulos-2--ahooremm/19114/Is telemedicine the next wave of medical practice? Michael J. Sacopulos, JD (www.medriskinstitute.com) weighs in.Thoughts on HIPAA
https://practicaldermatology.com/topics/practice-management/thoughts-on-hipaa/19206/Michael Sacopulos, JD discusses HIPAA compliance for aesthetic practices. (Recorded June 2013)AI: What it Means for Medicine
https://practicaldermatology.com/topics/practice-management/ai-what-it-means-for-medicine/19636/Justin Ko, MD, MBA shares his thoughts on how artificial and augmented intelligence will impact dermatology and discusses the AAD’s recent position statement on this technology.Rosacea Comorbidities and Skincare with Energy-Based Devices
https://practicaldermatology.com/programs/practical-dermatology/rosacea-comorbidities-and-skincare-with-energy-based-devices/35895/Ted Lain, MD, MBA, discusses the gut-skin connection as it relates to rosacea, as well as skincare with energy-based devices, at Music City SCALE 2025.Patient Portals
https://practicaldermatology.com/topics/practice-management/patient-portals/19113/Michael J. Sacopulos, JD, Founder and President of Medical Risk Institute (www.medriskinstitute.com), addresses the role, benefits, and potential pitfalls of patient portals.Meeting the Needs of Today's Injectables Market
https://practicaldermatology.com/videos/c-suite-chats/meeting-needs-todays-injectables-market/26926/David Moatazedi, president and CEO of Evolus, talks about trends in the injectables market and the needs of younger generations.